BOSTON — Ask Kate, an AI chatbot focused on answering questions about myopia management — based only on articles published on MyopiaProfile.com — is now in the process of launching, according to a speaker.Registered users of MyopiaProfile.com can sign …
Ask Kate outshines ChatGPT, other AI bots for myopia questions
BOSTON — Ask Kate, an AI chatbot focused on answering questions about myopia management — based only on articles published on MyopiaProfile.com — is now in the process of launching, according to a speaker.Registered users of MyopiaProfile.com can sign …
GenSight Biologics Announces Regulatory Authorization for Early Access Treatment with GS010/LUMEVOQ® in Israel
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and cent…
Healio announces appointment of first chief AI officer
Joan-Marie Stiglich, ELS, who has been with The Wyanoke Group for 31 years, will oversee Healio AI in the newly-created role, chief AI officer.Healio’s flagship AI product, Healio AI is a generative tool that is updated daily to deliver evidence-based …
Oral micronutrients show no impact on GA lesion growth
ORLANDO — Oral micronutrient supplementation showed no benefit on geographic atrophy lesion growth among a patient group from the OAKS and DERBY trials, according to a speaker.“We have had many post hoc analyses of recent trials that have shown that, p…
Viridian Therapeutics Announces BLA Acceptance and Priority Review for Veligrotug for the Treatment of Thyroid Eye Disease
WALTHAM, Mass.–(BUSINESS WIRE)–Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing, and commercializing potentially best-in-class medicines for serious and rare diseases, today announced that the U.S…